Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study

Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction

Ayman Geddawy, Yasmine Ibrahim, Nabil M. Elbahie et al. · Journal of Translational Internal Medicine · 2017 · 205 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China

Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan et al. · Gastroenterology · 2019 · 204 citations

Veterinary Medicine, Infectious Diseases, Hepatology +13

The efficacy and safety of direct acting antiviral treatment and clinical significance of drug–drug interactions in elderly patients with chronic hepatitis C virus infection

Johannes Vermehren, Kai‐Henrik Peiffer, Christoph Welsch et al. · Alimentary Pharmacology & Therapeutics · 2016 · 91 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis <scp>C</scp>

Benjamin Maasoumy, Kerstin Port, B. Calle Serrano et al. · Alimentary Pharmacology & Therapeutics · 2013 · 41 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC

Vicki Wing‐Ki Hui, Stephen L. Chan, Vincent Wai‐Sun Wong et al. · JHEP Reports · 2020 · 40 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14